AFATINIB for Egfr gene mutation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 780 adverse event reports in the FDA FAERS database where AFATINIB was used for Egfr gene mutation.
Most Reported Side Effects for AFATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 2,001 | 32.9% | 351 | 984 |
| Malignant neoplasm progression | 1,622 | 26.7% | 445 | 283 |
| Rash | 808 | 13.3% | 131 | 315 |
| Stomatitis | 468 | 7.7% | 77 | 234 |
| Death | 443 | 7.3% | 443 | 63 |
| Nausea | 430 | 7.1% | 69 | 280 |
| Decreased appetite | 412 | 6.8% | 85 | 255 |
| Vomiting | 381 | 6.3% | 67 | 271 |
| Paronychia | 344 | 5.7% | 62 | 133 |
| Dehydration | 323 | 5.3% | 56 | 276 |
| Fatigue | 256 | 4.2% | 52 | 128 |
| Metastases to central nervous system | 248 | 4.1% | 72 | 58 |
| Asthenia | 221 | 3.6% | 46 | 151 |
| Off label use | 204 | 3.4% | 64 | 37 |
| Drug ineffective | 203 | 3.3% | 31 | 47 |
Other Indications for AFATINIB
Non-small cell lung cancer (2,010)
Product used for unknown indication (916)
Lung adenocarcinoma (876)
Lung neoplasm malignant (824)
Non-small cell lung cancer metastatic (285)
Lung adenocarcinoma stage iv (146)
Adenocarcinoma (144)
Squamous cell carcinoma of head and neck (76)
Non-small cell lung cancer stage iv (74)
Lung cancer metastatic (68)
Other Drugs Used for Egfr gene mutation
OSIMERTINIB (695)
GEFITINIB (97)
AMIVANTAMAB-VMJW (89)
ERLOTINIB (52)
PEMETREXED (34)
CARBOPLATIN (30)
MOBOCERTINIB (26)
BEVACIZUMAB (25)
NINTEDANIB (24)
DOCETAXEL (17)